Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP285403.RAFh9kCMqF_sl7quOykHlZgdz9WTkIJj5sZQNyw6jazbQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP285403.RAFh9kCMqF_sl7quOykHlZgdz9WTkIJj5sZQNyw6jazbQ130_assertion type Assertion NP285403.RAFh9kCMqF_sl7quOykHlZgdz9WTkIJj5sZQNyw6jazbQ130_head.
- NP285403.RAFh9kCMqF_sl7quOykHlZgdz9WTkIJj5sZQNyw6jazbQ130_assertion description "[IL-2 -384 G/T was associated with better survival in oral cavity/oropharynx cancer (HR = 0.80; 95%CI = 0.45-1.42) and hypopharynx cancer (HR = 0.68; 95%CI = 0.21-2.20), but an inverse relationship was observed for larynx cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP285403.RAFh9kCMqF_sl7quOykHlZgdz9WTkIJj5sZQNyw6jazbQ130_provenance.
- NP285403.RAFh9kCMqF_sl7quOykHlZgdz9WTkIJj5sZQNyw6jazbQ130_assertion evidence source_evidence_literature NP285403.RAFh9kCMqF_sl7quOykHlZgdz9WTkIJj5sZQNyw6jazbQ130_provenance.
- NP285403.RAFh9kCMqF_sl7quOykHlZgdz9WTkIJj5sZQNyw6jazbQ130_assertion SIO_000772 21845339 NP285403.RAFh9kCMqF_sl7quOykHlZgdz9WTkIJj5sZQNyw6jazbQ130_provenance.
- NP285403.RAFh9kCMqF_sl7quOykHlZgdz9WTkIJj5sZQNyw6jazbQ130_assertion wasDerivedFrom befree-20140225 NP285403.RAFh9kCMqF_sl7quOykHlZgdz9WTkIJj5sZQNyw6jazbQ130_provenance.
- NP285403.RAFh9kCMqF_sl7quOykHlZgdz9WTkIJj5sZQNyw6jazbQ130_assertion wasGeneratedBy ECO_0000203 NP285403.RAFh9kCMqF_sl7quOykHlZgdz9WTkIJj5sZQNyw6jazbQ130_provenance.